676136-14-4

Usage

Uses

Used in Pharmaceutical Industry:
2-Pyridinecarbonitrile,4-(1-methylethyl)-(9CI) is used as an intermediate in the production of pharmaceuticals for its ability to be incorporated into the molecular structures of various drugs. Its unique chemical properties allow it to contribute to the development of medications with specific therapeutic effects.
Used in Agricultural Chemicals Industry:
In the agricultural sector, 2-Pyridinecarbonitrile,4-(1-methylethyl)-(9CI) serves as an intermediate in the synthesis of agricultural chemicals, such as pesticides and herbicides. Its role in these applications is crucial for enhancing crop protection and ensuring optimal yield.
Used in Research Applications:
2-Pyridinecarbonitrile,4-(1-methylethyl)-(9CI) is also utilized in research settings for the synthesis of new organic compounds. Its versatility in chemical reactions makes it a valuable tool for scientists exploring novel chemical entities and potential applications in various fields.

Upstream product

• 22581-87-9 4-isopropylpyridine 1-oxide 
• 7677-24-9 trimethylsilyl cyanide 
• 696-30-0 4-s-propylpyridine 

Downstream Products

• 900800-27-3 2-aminomethyl-4-isopropylpyridine 
• 947320-08-3 methyl 4-isopropylpicolinate 
• 261777-33-7 (2R,4S)-cis-4-(2-propyl)-1,2-piperidinedicarboxylic acid 1-(phenylmethyl) ester 
• 261777-39-3 (2R,4S)-cis-4-(2-propyl)-1,2-piperidinedicarboxylic acid 2-methyl 1-(phenylmethyl) diester 
• 261777-42-8 (2S,4S)-trans-4-(2-propyl)-1,2-piperidinedicarboxylic acid 2-methyl 1-(phenylmethyl) diester 
• 261777-45-1 (2S,4S)-trans-4-(2-propyl)-2-piperidinecarboxylic acid methyl ester 
• 756464-00-3 4-isopropyl-piperidine-2-carboxylic acid 
• 83282-36-4 4-isopropyl-pyridine-2-carboxylic acid 

Relevant academic research and scientific papers

PRODUCTION METHOD OF OPTICALLY ACTIVE SECONDARY ALCOHOL

PROBLEM TO BE SOLVED: To provide a chemical catalytic method allowing efficient production of a corresponding optically active secondary alcohol from an aromatic ketone having a substituent at each of two β-positions in an aromatic ring to the carbonyl site, so that both enantiomers can be separately made. SOLUTION: A production method of optically active secondary alcohol is characterized by reacting a ketone compound such as acetophenone derivatives with hydrogen in the presence of a ruthenium complex catalyst having an optically active diphosphine ligand. COPYRIGHT: (C)2015,JPO&INPIT

(3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING

The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease. (Formula)

Macrocyclic Compounds Useful as Bace Inhibitors

The invention relates to novel macrocyclic compounds of the formula (I), in which all of the variables are as defined in the specification, the number of ring atoms included in the macrocyclic ring being 14, 15, 16 or 17, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments comprising them.

Methods of treatment of amyloidosis using bi-aryl aspartyl protease inhibitors

The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INHIBITORS

The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

Synthesis of chiral nonracemic 4-trans-substituted pipecolic acid derivatives

The syntheses and resolutions of enantiomerically enriched 4-phenyl, 4- tert-butyl, and 4-isopropyl pipecolic acids are described. Optically active diastereomers were prepared by diastereomeric salt formation with the chiral base, L-tyrosine hydrazide, to